Newborn Screening Market Forecast 2023-2032: Key Trends, Growth Drivers, and Market Opportunities

The new-born screening market is projected to reach USD 1.02 Billion by 2032 at 8.20% CAGR during the forecast period 2023-2032.

The New-Born Screening market has witnessed significant growth in recent years, driven by the increasing awareness and importance of early detection and intervention in newborn health. Newborn screening, also known as neonatal screening, involves the testing of newborns for various genetic, metabolic, and developmental disorders. This process plays a crucial role in identifying potential health issues in infants, allowing for timely intervention and treatment.

One of the key components of newborn screening is newborn metabolic screening, which focuses on detecting metabolic disorders that may not be apparent at birth but can lead to severe health issues if left untreated. These disorders, such as phenylketonuria (PKU) and galactosemia, can be effectively managed if identified early. Newborn metabolic screening involves the collection of blood samples from newborns, which are then analyzed for specific markers indicative of metabolic abnormalities.

Another vital aspect of newborn screening is newborn hearing screening. Hearing impairment is a common congenital condition that, if not identified early, can lead to delays in speech and language development. Newborn hearing screening aims to detect hearing issues shortly after birth, enabling timely intervention and support for affected infants. This screening typically involves non-invasive methods, such as otoacoustic emissions (OAE) or auditory brainstem response (ABR) testing.

The global New-Born Screening market is witnessing a surge in demand due to the increasing emphasis on preventive healthcare and the rising prevalence of genetic disorders. Governments and healthcare organizations worldwide are recognizing the importance of implementing comprehensive newborn screening programs to ensure the well-being of the next generation. As a result, technological advancements in screening methods and increased investments in healthcare infrastructure are contributing to the market's growth.

Top of Form

Major Key Players:

MRFR recognizes the New-Born Screening Market Players are —SCIEX (US), PerkinElmer Inc. (US), WATERS (US), Natus Medical Incorporated (US), Masimo Corporation (US), Agilent Technologies Inc. (US), Bio-Rad Laboratories, Inc. (US), Medtronic (Ireland), GENERAL ELECTRIC (Boston), Trivitron Healthcare (India), and ZenTech SA (Belgium)

Segment Analysis

The global new-born screening market is segmented into product, technology, test type, and end-user

The global new-born screening market by-products has been bifurcated into instruments and reagents and assay kits.  By technology, the new-born screening market has been divided into newborn metabolic screening, DNA assays, electrophoresis, pulse oximetry, immunoassays, and enzymatic assays, and hearing screening technology. Based on the test type, it has been segregated into dry blood spot tests, critical congenital heart disease (CCHD) tests, urine tests, and hearing screening tests. The global new-born screening market, by end-user, has been classified as hospitals, maternity and specialty clinics, diagnostic centers, and others.

Regional Analysis

The global new-born screening market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas are anticipated to hold a significant share in the global new-born screening market. According to data published by the Centers for Disease Control and Prevention (CDC) in November 2018, congenital heart defects (CHD) affect approximately 1% or about 40,000 births per year in the US. Also, increasing awareness and rising demand for new-born screening are expected to drive market growth.

The new-born screening market in Europe is expected to propel owing to factors such as the rising prevalence of neonatal disorders and raising awareness about these disorders and their screening programs. According to a report published by the European Medicines Agency in May 2015, 1 in 10,000 babies born in the European Union was affected by perinatal asphyxia (a neonatal disorder wherein babies are born without enough oxygen in the blood). Also, technological advancements in the industry and government support in terms of National Health Service and health insurance are expected to drive market growth.

Asia-Pacific is anticipated to be the fastest-growing region in the global new-born screening market owing to the rising neonatal population, increasing mortality rate of neonates, and improving healthcare infrastructure. According to data published by the United Nation’s International Children’s Emergency Fund (UNICEF), the rate of neonatal mortality in India was 24% in 2017. According to a report published by the National Center for Biotechnology Information (NCBI) in December 2016, approximately 0.75 million neonates die in India every year. The neonatal mortality rate (NMR) for India is the highest for any country in the world. Also, the rising prevalence of neonatal disorders in developing countries and government support is fueling the growth in the market.

The new-born screening market in the Middle East & Africa is expected to significantly grow owing to the developing healthcare infrastructure and government support. The American Society of Hematology (ASH), led a campaign to fight the sickle cell disease in Africa in June 2018. It also urged the governments, particularly in Sub-Saharan Africa, to invest in new-born screening of the disease. Additionally, raising awareness of newborn screening is fueling the growth in the market.

For More Information, Please Visit @ Market Research Future

Comments

Post a Comment

Popular posts from this blog

Impact of COVID-19 Outbreak on Medical Billing Outsourcing Market – Industry Share Report 2027

  Medical Billing Outsourcing Market The growing emphasis on compliance and risk management and global expansion of some of the key players are some of the key factors driving the Medical Billing Outsourcing Market. In 2016, Allscripts acquired Core Medical Solutions, to increase its offerings in Australia. Allscripts currently supports more than 85 hospitals throughout Australia. Various other factors such as rising healthcare expenditure, increasing government support, and technological advancements are also expected to propel the growth of the market. The global  Medical Billing Outsourcing Market   is expected to grow at an approximate CAGR of 12.5% during the forecast period. However, increasing legislative & regulatory pressure, untapped emerging markets, Major Key Players: Some of the key players in the global Medical Billing Outsourcing Market are R1 RCM Inc., Allscripts, Cerner Corporation, EClinical Works, Experian Information Solutions Inc., GENERAL EL...
Read more

Global Microcarriers Market Size 2021 Expeditious Growth, Opportunities and forecast to 2027

  Microcarriers Market 2021 The Global  Microcarrier Market   Size  is anticipated to hold a market value of USD 1.18 billion with an estimated CAGR of 5.9% during the forecast period. A microcarrier is a support matrix allowing the growth of adherent cells. The microcarrier system provides high cell yields without having to resort to bulky equipment and tedious methodology. The rise in the use of microcarrier technology for various cell-based applications, coupled with the advantages of the microcarrier system such as its support for high yield of cells, facilitation of polarization and differentiation of cells, and lower risk of contamination are expected to drive the growth of the market during the forecast period. Moreover, the rapid growth of the biologics industry also fuels the growth of this market. On the other hand, strict regulatory framework, and limitation in production of high-density cell culture may hinder the growth of the market during the fore...
Read more

Non-Surgical Solutions on the Rise: Skin Tightening Market to Reach New Heights by 2032

The Skin Tightening Market is projected to grow from USD 1.13 Billion in 2023 to USD 3.3 billion by 2032, at a CAGR of 18.2% during the forecast. The global skin tightening market has witnessed significant growth in recent years, with a notable shift towards non-surgical and minimally invasive procedures. Consumers are increasingly seeking effective ways to rejuvenate their skin without the downtime and risks associated with traditional surgical methods. Non-surgical skin tightening and laser skin tightening have emerged as two prominent trends in this evolving market. Non-surgical skin tightening procedures utilize advanced technologies such as radiofrequency, ultrasound, and infrared light to stimulate collagen production and tighten the skin. These procedures are gaining popularity due to their minimal downtime, reduced risk of complications, and natural-looking results. Patients appreciate the convenience of non-surgical options that allow them to achieve a more youthful appe...
Read more